(Q56929669)

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Decline in daily running distance presages disease onset in a mouse model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

A randomized controlled trial of resistance exercise in individuals with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Inspiratory muscle training with a pressure threshold breathing device in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Inspiratory muscle training in patients with bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Effects of 8-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Respiratory muscle training in neuromuscular disease: long-term effects on strength and load perception.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Use of inspiratory muscle strength training to facilitate ventilator weaning: a series of 10 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Occlusion pressure as a measure of respiratory center output cm conscious man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Percutaneous nocturnal oximetry in amyotrophic lateral sclerosis: periodic desaturation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Quantitating progression in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

EQ-5D: a measure of health status from the EuroQol Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

The ALSFRSr predicts survival time in an ALS clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

Diaphragm Training in Amyotrophic Lateral Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052

INSPIRATIonAL – INSPIRAtory muscle training in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.626052